Clinical trial
A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects…
NCT00267280 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00267280 |
|---|---|
| Title | A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). |
| Official title | A Phase 3, Open-Label, Multisite, Randomized, Parallel Group Study of the Efficacy and Safety of Fixed Combination Torcetrapib/Atorvastatin Administered Once Daily (QD) Compared to Simvastatin for 6 Weeks in Subjects With Hypercholesterolemia (A5091031) |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Dyslipidemia, Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, simvastatin |
| Enrollment | 640 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Dec 20, 2005 |
| Last update posted | Feb 17, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: